Cite

HARVARD Citation

    Abboud, C. et al. (n.d.). P501: CLI120-001 PHASE1B DOSE ESCALATION STUDY OF RVU120 IN PATIENTS WITH AML OR HIGH RISK MDS SAFETY AND EFFICACY DATA UPDATE. HemaSphere. pp. 400-401. [Online]. 
  
Back to record